MetaCap

Trulieve Cannabis Subordinate Voting Shares Earnings

NYSE: TRLVHealth Care Medicinal Chemicals and Botanical Products USD

10.67+0.30 (+2.89%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Before market open

Fiscal period

Sep/2026

EPS estimate

$0.09

Trulieve Cannabis Subordinate Voting Shares earnings summary

Trulieve Cannabis Subordinate Voting Shares is scheduled to report Sep/2026 earnings on Nov 5, 2026 before the market opens, with analysts expecting EPS of $0.09. In its most recent report on Aug 7, 2026 (Q2 2026), TRLV posted EPS of $-2.10. Revenue for the quarter was $271.0 million.

Across the last 16 reports, TRLV shares moved an average of 7.9% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.

Summary generated from market data by MetaCap's automated system. Methodology

TRLV earnings history

Trulieve Cannabis Subordinate Voting Shares reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 7, 2026—$-2.10—+10.3%
May 7, 2026—$0.02—-17.5%
Feb 26, 2026—$-0.24—+3.4%
Nov 5, 2025—$-0.11—-17.2%
Aug 6, 2025—$-0.07—+31.1%
May 7, 2025—$-0.16—+2.4%
Feb 27, 2025—$-0.27—-0.2%
Nov 5, 2024—$-0.32—-3.1%
Aug 6, 2024—$-0.04—+2.0%
May 9, 2024—$-0.16—+5.6%
Feb 29, 2024—$-0.18—-3.8%
Nov 9, 2023—$-0.12—+3.9%
Aug 9, 2023—$-1.80—-4.2%
May 10, 2023—$-0.18—-5.8%
Mar 8, 2023—$-0.32—+1.1%
Nov 9, 2022—$-0.38—+14.6%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related